Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Pharmacovigilance Software Market Status and Forecast (2017-2028)
  • 1.3.2 Global Pharmacovigilance Software Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Pharmacovigilance Software Supply by Company

• 2.1 Global Pharmacovigilance Software Sales Value by Company
• 2.2 Pharmacovigilance Software Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Pharmacovigilance Software Market Status by Type

• 3.1 Pharmacovigilance Software Type Introduction
  • 3.1.1 ADR Reporting
  • 3.1.2 Drug Safety Audits
  • 3.1.3 Issue Tracking
  • 3.1.4 Fully Integrated Software
• 3.2 Global Pharmacovigilance Software Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Pharmacovigilance Software Market Status by Application

• 4.1 Pharmacovigilance Software Segment by Application
  • 4.1.1 Pharma & biotech companies
  • 4.1.2 CROs
  • 4.1.3 BPOs
  • 4.1.4 Others
• 4.2 Global Pharmacovigilance Software Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Pharmacovigilance Software Market Status by Region

• 5.1 Global Pharmacovigilance Software Market by Region
• 5.2 North America Pharmacovigilance Software Market Status
• 5.3 Europe Pharmacovigilance Software Market Status
• 5.4 Asia Pacific Pharmacovigilance Software Market Status
• 5.5 Central & South America Pharmacovigilance Software Market Status
• 5.6 Middle East & Africa Pharmacovigilance Software Market Status

6 North America Pharmacovigilance Software Market Status

• 6.1 North America Pharmacovigilance Software Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Pharmacovigilance Software Market Status

• 7.1 Europe Pharmacovigilance Software Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Pharmacovigilance Software Market Status

• 8.1 Asia Pacific Pharmacovigilance Software Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Pharmacovigilance Software Market Status

• 9.1 Central & South America Pharmacovigilance Software Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Pharmacovigilance Software Market Status

• 10.1 Middle East & Africa Pharmacovigilance Software Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Pharmacovigilance Software Market Forecast by Type and by Application

• 12.1 Global Pharmacovigilance Software Sales Value Forecast (2023-2028)
• 12.2 Global Pharmacovigilance Software Forecast by Type
• 12.3 Global Pharmacovigilance Software Forecast by Application

13 Global Pharmacovigilance Software Market Forecast by Region/Country

• 13.1 Global Pharmacovigilance Software Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 United BioSource Corporation
  • 14.1.1 Company Information
  • 14.1.2 Pharmacovigilance Software Product Introduction
  • 14.1.3 United BioSource Corporation Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Sparta Systems
  • 14.2.1 Company Information
  • 14.2.2 Pharmacovigilance Software Product Introduction
  • 14.2.3 Sparta Systems Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Relsys
  • 14.3.1 Company Information
  • 14.3.2 Pharmacovigilance Software Product Introduction
  • 14.3.3 Relsys Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 Oracle Corporation
  • 14.4.1 Company Information
  • 14.4.2 Pharmacovigilance Software Product Introduction
  • 14.4.3 Oracle Corporation Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Online Business Applications
  • 14.5.1 Company Information
  • 14.5.2 Pharmacovigilance Software Product Introduction
  • 14.5.3 Online Business Applications Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Max Application
  • 14.6.1 Company Information
  • 14.6.2 Pharmacovigilance Software Product Introduction
  • 14.6.3 Max Application Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 EXTEDO GmbH
  • 14.7.1 Company Information
  • 14.7.2 Pharmacovigilance Software Product Introduction
  • 14.7.3 EXTEDO GmbH Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 Ennov Solutions
  • 14.8.1 Company Information
  • 14.8.2 Pharmacovigilance Software Product Introduction
  • 14.8.3 Ennov Solutions Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.8.4 SWOT Analysis
• 14.9 ArisGlobal
  • 14.9.1 Company Information
  • 14.9.2 Pharmacovigilance Software Product Introduction
  • 14.9.3 ArisGlobal Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.9.4 SWOT Analysis
• 14.10 AB Cube
  • 14.10.1 Company Information
  • 14.10.2 Pharmacovigilance Software Product Introduction
  • 14.10.3 AB Cube Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.10.4 SWOT Analysis

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Pharmacovigilance Software market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pharmacovigilance Software industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Pharmacovigilance Software market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pharmacovigilance Software Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance Software market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Pharmacovigilance Software Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Pharmacovigilance Software industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software

Segmented by Application
Pharma & biotech companies
CROs
BPOs
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
United BioSource Corporation
Sparta Systems
Relsys
Oracle Corporation
Online Business Applications
Max Application
EXTEDO GmbH
Ennov Solutions
ArisGlobal
AB Cube